174 related articles for article (PubMed ID: 29362258)
1. Cost-effectiveness of FreeO
Poder TG; Kouakou CRC; Bouchard PA; Tremblay V; Blais S; Maltais F; Lellouche F
BMJ Open; 2018 Jan; 8(1):e018835. PubMed ID: 29362258
[TBL] [Abstract][Full Text] [Related]
2. Automated oxygen titration and weaning with FreeO2 in patients with acute exacerbation of COPD: a pilot randomized trial.
Lellouche F; Bouchard PA; Roberge M; Simard S; L'Her E; Maltais F; Lacasse Y
Int J Chron Obstruct Pulmon Dis; 2016; 11():1983-90. PubMed ID: 27601891
[TBL] [Abstract][Full Text] [Related]
3. Automated oxygen administration versus conventional oxygen therapy after major abdominal or thoracic surgery: study protocol for an international multicentre randomised controlled study.
L'her E; Jaber S; Verzilli D; Jacob C; Huiban B; Futier E; Kerforne T; Pateau V; Bouchard PA; Gouillou M; Nowak E; Lellouche F
BMJ Open; 2019 Jan; 9(1):e023833. PubMed ID: 30782716
[TBL] [Abstract][Full Text] [Related]
4. Automatic Oxygen Titration During Walking in Subjects With COPD: A Randomized Crossover Controlled Study.
Lellouche F; L'Her E; Bouchard PA; Brouillard C; Maltais F
Respir Care; 2016 Nov; 61(11):1456-1464. PubMed ID: 27794080
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations.
Khoudigian-Sinani S; Kowal S; Suggett JA; Coppolo DP
Int J Chron Obstruct Pulmon Dis; 2017; 12():3065-3073. PubMed ID: 29089755
[TBL] [Abstract][Full Text] [Related]
6. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
Chiang CH
Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
[TBL] [Abstract][Full Text] [Related]
7. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
8. Automated O
Vivodtzev I; L'Her E; Vottero G; Yankoff C; Tamisier R; Maltais F; Lellouche F; Pépin JL
Thorax; 2019 Mar; 74(3):298-301. PubMed ID: 30166425
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada.
Poder TG; Carrier N; Bélanger M; Couillard S; Courteau J; Larivée P; Vanasse A
Int J Chron Obstruct Pulmon Dis; 2018; 13():3065-3076. PubMed ID: 30349220
[TBL] [Abstract][Full Text] [Related]
10. Controlled oxygen therapy at emergency department presentation increases the likelihood of achieving target oxygen saturations in patients with exacerbations of chronic obstructive pulmonary disease.
Chow JW; Khullar K; Katechia K; Klim S; Kelly AM
Emerg Med Australas; 2016 Feb; 28(1):44-7. PubMed ID: 26748625
[TBL] [Abstract][Full Text] [Related]
11. Automated oxygen control with O2matic
Hansen EF; Hove JD; Bech CS; Jensen JS; Kallemose T; Vestbo J
Int J Chron Obstruct Pulmon Dis; 2018; 13():3997-4003. PubMed ID: 30587955
[TBL] [Abstract][Full Text] [Related]
12. Automatic oxygen administration and weaning in patients following mechanical ventilation.
Ouanes I; Bouhaouala F; Maatouk S; Lahmar M; Ben Abdallah S; Hammouda Z; Dachraoui F; Ouanes-Besbes L; L'Her E; Abroug F
J Crit Care; 2021 Feb; 61():45-51. PubMed ID: 33075609
[TBL] [Abstract][Full Text] [Related]
13. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
Moll K; Sun SX; Ellis JJ; Howe A; Amin A
Int J Chron Obstruct Pulmon Dis; 2015; 10():565-76. PubMed ID: 25834417
[TBL] [Abstract][Full Text] [Related]
14. Long-term air humidification therapy is cost-effective for patients with moderate or severe chronic obstructive pulmonary disease or bronchiectasis.
Milne RJ; Hockey H; Rea H
Value Health; 2014 Jun; 17(4):320-7. PubMed ID: 24968990
[TBL] [Abstract][Full Text] [Related]
15. An international randomized study of a home-based self-management program for severe COPD: the COMET.
Bourbeau J; Casan P; Tognella S; Haidl P; Texereau JB; Kessler R
Int J Chron Obstruct Pulmon Dis; 2016; 11():1447-51. PubMed ID: 27418817
[TBL] [Abstract][Full Text] [Related]
16. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.
Rutten-van Mölken MP; van Nooten FE; Lindemann M; Caeser M; Calverley PM
Pharmacoeconomics; 2007; 25(8):695-711. PubMed ID: 17640111
[TBL] [Abstract][Full Text] [Related]
17. Resource use and risk factors in high-cost exacerbations of COPD.
Oostenbrink JB; Rutten-van Mölken MP
Respir Med; 2004 Sep; 98(9):883-91. PubMed ID: 15338802
[TBL] [Abstract][Full Text] [Related]
18. Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).
Friedman M; Menjoge SS; Anton SF; Kesten S
Pharmacoeconomics; 2004; 22(11):741-9. PubMed ID: 15250751
[TBL] [Abstract][Full Text] [Related]
19. Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial.
Lacasse Y; Bernard S; Sériès F; Nguyen VH; Bourbeau J; Aaron S; Maltais F;
BMC Pulm Med; 2017 Jan; 17(1):8. PubMed ID: 28069009
[TBL] [Abstract][Full Text] [Related]
20. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
